Medications called biologic response modifiers, such as adalimumab (Humira), infliximab (Remicade), and etanercept (Enbrel), have been used for many autoimmune diseases, but are still under investigation for endometriosis. Biologic response modifiers inhibit cytokines, which decrease pain and inflammation.
These drugs are expensive and must be given intravenously or by injection. They may also increase the risk of infections. Some can have a bad effect on the neurological system, making them unacceptable for use in some patients.
Was this article helpful?